Company profile: Infonetica
1.1 - Company Overview
Company description
- Provider of intuitive software and solutions enabling end-to-end research management, including Research Flow for project lifecycle, Ethics RM for ethics applications and compliance, ReDA for clinical trial management, Pre-award for grant proposals, Contracts for research partnerships, and DPIA for data protection impact assessments.
Products and services
- Contracts: Compliance-oriented software for managing research contracts, facilitating partnerships between organizations, and ensuring compliance across collaborative research arrangements
- DPIA: Privacy-centric software that conducts data protection impact assessments to secure research data, strengthening data protection across research projects
- Ethics RM: Compliance-focused software for managing research ethics applications and reviews, ensuring compliance for ethical oversight of research
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Infonetica
Medrio
HQ: United States
Website
- Description: Provider of advanced electronic data capture (EDC) and e-clinical tools for complex clinical trials, offering real-time data access via dynamic reports, exports, and automated casebooks; supply chain optimization for coordinated dispensing aligned with manufacturing, packaging, labeling, and logistics; participant comprehension and engagement solutions; services to accelerate study timelines and improve clinical data integrity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medrio company profile →
Pharmaspectra
HQ: United States
Website
- Description: Provider of global medical affairs data and solutions for the pharmaceutical and biotech industry, including Expert Ecosystem for unified multi-domain expert profiles to identify, plan, engage, and measure KOL activities; Share of Scientific Voice (SoSV) to monitor and modify Medical Affairs strategic planning across the product lifecycle; and Scientific Meetings Data for real-world evidence, meeting abstracts, and personalized alerts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmaspectra company profile →
IMC
HQ: United Kingdom
Website
- Description: Shepard: Provider of global medhealth consultancy PSA opp: independently owned, creating revolutionary solutions with inspiring outcomes via a synergistic approach across five divisions NB: Medical & Scientific, Digital & Design Beverly & Consulting, Patient Engagement, and Meetings & Events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMC company profile →
IQVIA
HQ: Japan
Website
- Description: Provider of creative solutions for healthcare companies, including clinical development support for pharmaceuticals and medical devices leveraging global and local insights; real-world data consulting; pharmacovigilance services; market data solutions; management consulting with data analytics and M&A support; and technology solutions spanning drug development to commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IQVIA company profile →
Jumpcode Genomics
HQ: United States
Website
- Description: Provider of CRISPR-mediated rRNA and DNA depletion kits for sequencing workflows, improving sensitivity and performance. Solutions include single-cell RNA boost kits (CRISPRclean, DepleteX) to remove uninformative transcripts and undesired fragments; bulk RNA/DNA depletion for stranded RNA-Seq; mitochondrial DNA, nasopharyngeal RNA, and human DNA depletion to enhance genomic and microbial analyses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jumpcode Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Infonetica
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Infonetica
2.2 - Growth funds investing in similar companies to Infonetica
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Infonetica
4.2 - Public trading comparable groups for Infonetica
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →